|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/45 |
| (11) | Number of the document | 2040548 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07812295.9 |
| Date of filing the European patent application | 2007-06-25 | |
| (97) | Date of publication of the European application | 2009-04-01 |
| (45) | Date of publication and mention of the grant of the patent | 2012-05-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/072016 |
| Date | 2007-06-25 |
| (87) | Number | WO 2007/150064 |
| Date | 2007-12-27 |
| (30) | Number | Date | Country code |
| 815952 P | 2006-06-23 | US |
| (72) |
WUSTMAN, Brandon, US
|
| (73) |
Amicus Therapeutics, Inc.,
6 Cedar Brook Drive, Cranbury, NJ 08512,
US
|
| (54) | METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS BY ENHANCING THE ACTIVITY OF BETA -GLUCOCEREBROSIDASE |
| METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS BY ENHANCING THE ACTIVITY OF BETA -GLUCOCEREBROSIDASE |